CompletedNot Applicable

The Effect of Walking and Grounding in Women With Breast Cancer

Turkey (Türkiye)55 participantsStarted 2025-01-30

Plain-language summary

This randomized controlled trial was conducted to examine the effect of walking and grounding on pain intensity, fatigue level and sleep quality in women diagnosed with breast cancer.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age or older, * Can read and write and speak Turkish, * Diagnosed with primary breast cancer and know the diagnosis, * Volunteered to participate in the research, * Living in Ankara province, * Paclitaxel or Paclitaxel-Transtuzumab based chemotherapy treatment initiated, * Eastern Cooperative Oncology Group (ECOG) Scale 0 or 1, * NCI-CTCAE v5.0 Pain, fatigue and sleep toxicity grade 1 or 2, * You have a phone with an iOS or Android processor, Exclusion Criteria: * Open wounds or edema of the hands and feet, * NCI-CTCAE v5.0 motor and sensory peripheral neuropathy with toxicity grade 3,4 or 5, * People with a disability that would prevent them from walking, * Diagnosed cardiovascular and pulmonary disorders, * Diagnosed neurological or psychiatric illness, * Communication problems, * Bone metastases, * Bilateral mastectomies, Criteria for Withdrawal from the Study: * Withdrawal from the study at any stage, * Hospitalization, * Failure to follow the guidelines or perform the intervention-walking for 30 minutes at least three times a week or walking plus grounding-in the intervention group, * Starting a regular exercise program during the study period in the control group.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Visual Analog Scale

Timeframe: 0,4,8 weeks

Trial details

NCT IDNCT06767059

SponsorAnkara University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-18

View on ClinicalTrials.gov More Breast Cancer trials